Skip to main content

Published locations for Natalizumab switch to moderate-efficacy DMT increases disability risk

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Natalizumab switch to moderate-efficacy DMT increases disability risk

User login

  • Reset your password
  • /content/natalizumab-switch-moderate-efficacy-dmt-increases-disability-risk
  • /neurologyreviews/article/222968/multiple-sclerosis/natalizumab-switch-moderate-efficacy-dmt
  • /multiplesclerosishub/article/222968/multiple-sclerosis/natalizumab-switch-moderate-efficacy-dmt
  • /neurology/article/222968/multiple-sclerosis/natalizumab-switch-moderate-efficacy-dmt-increases
  • /neurology/msresourcecenter/article/222968/multiple-sclerosis/natalizumab-switch-moderate-efficacy